Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study
Miao Wang,1,* Jin Shi,2,* Kepei Zhang,1,* Jie Hong,2,* Xinwei Peng,2 Yu Tian,1 Wei Lu,3 Ke Li,2 Zengliang Wang,4 Feng Li,1 Zhijie Zhang,2 Guojiang Mei1 1Department of Internal Medicine of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Tradition...
Main Authors: | Wang M, Shi J, Zhang K, Hong J, Peng X, Tian Y, Lu W, Li K, Wang Z, Li F, Zhang Z, Mei G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-03-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-longyizhengqi-granule-in-treatment-of-mild-covi-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Clinical characteristics and risk factors analysis of viral shedding time in mildly symptomatic and asymptomatic patients with SARS-CoV-2 Omicron variant infection in Shanghai
by: Ran Li, et al.
Published: (2023-01-01) -
The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves
by: Franz Konstantin Fuss, et al.
Published: (2022-12-01) -
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
by: Prerna Arora, et al.
Published: (2022-11-01) -
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
by: Danyi Ao, et al.
Published: (2022-03-01) -
Impact of SARS-CoV-2 Omicron variant infection on the outcomes of patients with spontaneous intracerebral hemorrhage: A prospective cohort study
by: Sai Du, et al.
Published: (2024-02-01)